| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Department of Molecular Genetics and
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
The hepatitis B virus (HBV) core Ag (HBcAg) serves as the structural subunit of the highly immunogenic capsid shell. HBcAg harbors a unique arginine-rich C terminus that was implicated in immune responses induced by the capsid. In this study, we examined the capacity of the HBV capsid to induce proinflammatory and regulatory cytokines in human THP-1 macrophages and the possible underlying mechanism. Full-length HBc capsids, but not HBc-144 capsids lacking the arginine-rich domain of HBcAg, efficiently bound differentiated THP-1 macrophages and strongly induced TNF-
, IL-6, and IL-12p40. Capsid binding to macrophages and cytokine induction were independent of the RNA associated with the arginine-rich domain. Soluble heparin and heparan sulfate but not chondroitin sulfates greatly diminished cytokine induction through inhibition of capsid binding to THP-1 macrophages. Furthermore, serine phosphorylation in the arginine-rich domain modulates capsid binding to macrophages and the cytokine response. Induction of cytokines by the capsid involved activation of NF-
B, ERK-1/2, and p38 MAPK and did not require endosomal acidification. Finally, NF-B activation by the capsid in HEK 293 cells specifically required expression of TLR2 and was compromised by soluble heparin. Thus, cytokine induction by the HBV capsid in macrophages is facilitated by interaction of its arginine-rich domain with membrane heparan sulfate and involves signaling through TLR2.
This article has been cited by other articles:
|
|
 |
|
  B. O. Lee, A. Tucker, L. Frelin, M. Sallberg, J. Jones, C. Peters, J. Hughes, D. Whitacre, B. Darsow, D. L. Peterson, et al. Interaction of the Hepatitis B Core Antigen and the Innate Immune System J. Immunol., June 1, 2009; 182(11): 6670 - 6681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Mencin, J Kluwe, and R F Schwabe Toll-like receptors as targets in chronic liver diseases Gut, May 1, 2009; 58(5): 704 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heydtmann Macrophages in Hepatitis B and Hepatitis C Virus Infections J. Virol., April 1, 2009; 83(7): 2796 - 2802. [Full Text] [PDF]
|
|
|
|
|
|
M.-E. Ariza, R. Glaser, P. T. P. Kaumaya, C. Jones, and M. V. Williams The EBV-Encoded dUTPase Activates NF-{kappa}B through the TLR2 and MyD88-Dependent Signaling Pathway J. Immunol., January 15, 2009; 182(2): 851 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Broos, M. E. Janssens, I. De Goeyse, P. Vanlandschoot, G. Leroux-Roels, D. Geysen, and Y. Guisez Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit Clin. Vaccine Immunol., May 1, 2008; 15(5): 852 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gaudreault, S. Fiola, M. Olivier, and J. Gosselin Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2 J. Virol., August 1, 2007; 81(15): 8016 - 8024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. Zhao, X.-L. Zhang, P. Zhao, J. Cao, M.-M. Cao, S.-Y. Zhu, H.-Q. Liu, and Z.-T. Qi Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line J. Leukoc. Biol., August 1, 2006; 80(2): 424 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cooper and Y. Shaul Clathrin-mediated Endocytosis and Lysosomal Cleavage of Hepatitis B Virus Capsid-like Core Particles J. Biol. Chem., June 16, 2006; 281(24): 16563 - 16569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vanlandschoot, G. Leroux-Roels, A. Cooper, G. Tal, and Y. Shaul The Role of Heparan Sulfate and TLR2 in Cytokine Induction by Hepatitis B Virus Capsids J. Immunol., November 15, 2005; 175(10): 6253 - 6255. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
